Christopher G. Armstrong
8Patents
2h-index
15Co-inventors
48Inventor score
Filing activity: Dec 15, 1999 → Oct 7, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7452664B2 | Methods for identifying agents which alter histone protein acetylation | Emerging Cross-Sectional Technologies | 4 | Expired |
| US10874633B2 | Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity | Human Necessities | 2 | Active |
| US10806716B2 | Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity | Human Necessities | 2 | Active |
| US11166936B2 | Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity | Human Necessities | 1 | Active |
| US8642284B1 | Methods for identifying agents that alter NAD-dependent deacetylation activity of a SIR2 protein | Physics | 0 | Expired |
| US8652797B2 | Methods of NAD-dependent deacetylation of a lysine residue in a protein | Emerging Cross-Sectional Technologies | 0 | Active |
| US11786503B2 | Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity | Human Necessities | 0 | Active |
| US6710026B1 | Protein domains in the hepatic glycogen-targetting subunit of protein phosphatase 1 and methods of making and using the same | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.